Physician profile
Robert Marvin
NPI 1316006554
$16,738.96
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,884 · 2020: $14K · 2021: $285 · 2022: $503 · 2023: $311 · 2024: $37.69.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $349.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $348.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $14,642.93 | 2019-2023 | Da Vinci Surgical System |
| Apollo Endosurgery US INC | $506.55 | 2019-2023 | Overstitch Endoscopic Suturing System |
| Ethicon US, LLC | $385.73 | 2019-2023 | Echelon Flex, Echelon Endopath |
| Asensus Surgical, INC. | $350.86 | 2019 | |
| Endo Pharmaceuticals INC. | $333.73 | 2019-2022 | |
| Vivus LLC | $213.44 | 2019-2024 | Qsymia |
| Standard Bariatrics, INC. | $127.97 | 2022 | |
| Allergan, INC. | $52.59 | 2021 | |
| Innocoll Pharmaceuticals Limited | $34.45 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $29.51 | 2019 | |
| Tela Bio, INC. | $22.02 | 2024 | Ovitex 2s |
| Baxter Healthcare | $21.65 | 2020 | |
| Covidien LP | $17.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Marvin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.